Akmaev VR - Search Results

1

Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis.

Curtis JR, Strand V, Golombek SJ, Karpouzas GA, Zhang L, Wong A, Patel K, Dines J, Akmaev VR. Curtis JR, et al. Among authors: akmaev vr. Rheumatol Ther. 2024 Feb;11(1):61-77. doi: 10.1007/s40744-023-00618-1. Epub 2023 Nov 10. Rheumatol Ther. 2024. PMID: 37948030 Free PMC article.

2

Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis.

Curtis JR, Strand V, Golombek S, Zhang L, Wong A, Zielinski MC, Akmaev VR, Saleh A, Asgarian S, Withers JB. Curtis JR, et al. Among authors: akmaev vr. Expert Rev Mol Diagn. 2022 Nov 3:1-10. doi: 10.1080/14737159.2022.2140586. Online ahead of print. Expert Rev Mol Diagn. 2022. PMID: 36305319

3

Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis.

Cohen S, Curtis JR, Mellors T, Zhang L, Withers JB, Jones A, Ghiassian SD, Akmaev VR. Cohen S, et al. Among authors: akmaev vr. Rheumatol Ther. 2023 Feb;10(1):1-6. doi: 10.1007/s40744-022-00506-0. Epub 2022 Nov 27. Rheumatol Ther. 2023. PMID: 36441482 Free PMC article.

4

The module triad: a novel network biology approach to utilize patients' multi-omics data for target discovery in ulcerative colitis.

Voitalov I, Zhang L, Kilpatrick C, Withers JB, Saleh A, Akmaev VR, Ghiassian SD. Voitalov I, et al. Among authors: akmaev vr. Sci Rep. 2022 Dec 15;12(1):21685. doi: 10.1038/s41598-022-26276-x. Sci Rep. 2022. PMID: 36522454 Free PMC article.

5

Retraction notice to "Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis" Translational Research 239C (2021) 35-43.

Akmaev VR, Ghiassian SD, Withers JB, Santolini M, Saleh A. Akmaev VR, et al. Transl Res. 2022 Jun;244:137. doi: 10.1016/j.trsl.2022.03.011. Transl Res. 2022. PMID: 35589246 No abstract available.

6

Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis.

Ghiassian SD, Voitalov I, Withers JB, Santolini M, Saleh A, Akmaev VR. Ghiassian SD, et al. Among authors: akmaev vr. Transl Res. 2022 Aug;246:78-86. doi: 10.1016/j.trsl.2022.03.006. Epub 2022 Mar 16. Transl Res. 2022. PMID: 35306220 Free article.

7

A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.

Cohen S, Akmaev VR, Withers JB, Connolly-Strong E. Cohen S, et al. Among authors: akmaev vr. Rheumatol Ther. 2022 Feb;9(1):309-311. doi: 10.1007/s40744-021-00387-9. Epub 2021 Nov 10. Rheumatol Ther. 2022. PMID: 34757533 Free PMC article. No abstract available.

8

Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis.

Jones A, Rapisardo S, Zhang L, Mellors T, Withers JB, Gatalica Z, Akmaev VR. Jones A, et al. Among authors: akmaev vr. Expert Rev Mol Diagn. 2021 Nov;21(11):1235-1243. doi: 10.1080/14737159.2021.2000394. Epub 2021 Nov 10. Expert Rev Mol Diagn. 2021. PMID: 34727834

9

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia.

Kiebish MA, Tekumalla P, Ravipaty S, Dobi A, Srivastava S, Wu W, Patil S, Friss T, Klotz A, Srinivasan A, Cullen J, Rosner IL, Ali A, Laszlo S, Petrovic M, Fleshner N, Garren J, Miller G, Mahaveer Chand N, Rodrigues LO, Granger E, Kellogg MD, Luan S, Diamandis E, Akmaev VR, Sarangarajan R, Bountra C, Freedland SJ, McLeod DG, Narain NR. Kiebish MA, et al. Among authors: akmaev vr. Sci Rep. 2021 Jul 23;11(1):15052. doi: 10.1038/s41598-021-94438-4. Sci Rep. 2021. PMID: 34302010 Free PMC article.

10

A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.

Cohen S, Wells AF, Curtis JR, Dhar R, Mellors T, Zhang L, Withers JB, Jones A, Ghiassian SD, Wang M, Connolly-Strong E, Rapisardo S, Gatalica Z, Pappas DA, Kremer JM, Saleh A, Akmaev VR. Cohen S, et al. Among authors: akmaev vr. Rheumatol Ther. 2021 Sep;8(3):1159-1176. doi: 10.1007/s40744-021-00330-y. Epub 2021 Jun 19. Rheumatol Ther. 2021. PMID: 34148193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page